An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)
This study has been withdrawn prior to enrollment.
(Study halted prior to enrollment of first participant)
Sponsor:
Shire Human Genetic Therapies, Inc.
Collaborators:
PharmaNet
Nextrials, Inc.
Information provided by:
Shire Human Genetic Therapies, Inc.
ClinicalTrials.gov Identifier:
NCT01093105
First received: March 24, 2010
Last updated: October 6, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | September 2012 |
| Estimated Primary Completion Date: | May 2012 (Final data collection date for primary outcome measure) |